Fitness and Nutrition in Glioma
Part of paid clinical trials in New York, New York.
- Sponsor
- NYU Langone Health
- Study ID
- NCT06665373
- Status
- Recruiting
Conditions
- Malignant Glioma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 100 Years
- Healthy Volunteers
- Not accepted
Interventions
- Modified Atkins Diet — BEHAVIORALThe Atkins diet is a low-carb eating plan that focuses on balancing protein, fat, and carbohydrates.
- Fitness Program — BEHAVIORAL12 weeks of two weekly supervised exercise sessions combined with an individualized home exercise program based on physical capabilities and available equipment.
Study Details
This is a pilot study assessing the effects of combining a modified Atkins diet with a physical fitness regimen in patients with malignant glioma. A sample size of 15 participants will be enrolled in a 15-week program consisting of two weekly supervised exercise sessions combined with an individualized home exercise program and a modified Atkins diet.
Key Dates
- Start date
- Oct 1, 2024
- Status verified
- Aug 2025
- Primary completion
- Oct 31, 2026
- Completion
- Oct 31, 2026
Study Design
- Enrollment
- 15 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Patients Diagnosed with Malignant GliomaPatients will participate in a 15-week program consisting of two weekly supervised exercise sessions combined with an individualized home exercise program and a modified Atkins diet.
Primary Outcome Measure
Change in Short Form (SF)-36 Version 2 Score [ Time Frame: Baseline, Week 12 ]
Central Contacts
- Cathryn Lapierre646-201-5762
- Lee Tessler, MD516-324-7500
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| NYU Langone Health | New York | New York | 10016 | - |
Find similar trials in New York, NY
By research site
Related Studies
- A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)PHASE1/PHASE2 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama
- Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing SurgeryPHASE1/PHASE2 · Recruiting · Stanford University · Palo Alto, California
- Non-invasive Glioma Characterization Through Molecular ImagingRecruiting · University of Miami · Miami, Florida
- Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young AdultsPHASE1 · Recruiting · Sabine Mueller, MD, PhD · Birmingham, Alabama